Gallo O, Franchi A, Chiarelli I, Porfirio B, Grande A, Simonetti L, Bocciolini C, Fini-Storchi O
Institute of Otolaryngology-Head & Neck Surgery, University of Florence, Italy.
Acta Otolaryngol Suppl. 1997;527:30-8. doi: 10.3109/00016489709124030.
Factors contributing to malignant transformation of laryngeal pre-neoplastic lesions remain largely unknown. Potential etiologic factors may be related to a genetically controlled sensitivity to environmental carcinogens. In this study, we investigated bleomycin-induced chromosome fragility in 15 patients with laryngeal keratoses who experienced a malignant transformation of pre-neoplastic lesions during follow-up, as compared with chromosome fragility in 15 historical controls with no progression of laryngeal keratoses during a 10-year follow-up, in a match-paired analysis. Chromosomal analysis demonstrated a higher sensitivity to clastogens in patients with malignant progression of laryngeal pre-neoplastic lesions than that of control patients with no evolution of their original laryngeal keratoses (p < 0.01). Furthermore, in the attempt to identify possible prognostic markers we studied proliferative activity (MIB-1 expression) and p53 gene aberration in biopsy samples from non-invasive and invasive laryngeal lesions in both groups. p53 immunostaining was observed in 10/15 (66.7%) of pre-neoplastic lesions and in 11/15 (73.3%) of metachronous laryngeal cancers. No differences in terms of p53 expression were noted between transformed and not-transformed lesions. Mutations at p53 gene were observed in 3/15 (20%) of pre-invasive biopsies and in 4/5 (80%) of the laryngeal cancers analyzed. Our data suggest that p53 alteration is an early event in the genesis of a subset of laryngeal carcinomas and that there is no conclusive data about the possible clonal development of metachronous laryngeal carcinoma from a p53 mutated pre-invasive disease in the same patient. MIB-1 expression was found to progressively increase with degree of epithelial hyperplasia and dysplasia in both transformed (p = 0.007) and not-transformed (p < 0.1) lesions. Surprisingly, pre-invasive lesions with tumor evolution showed a lower proliferative activity when compared with laryngeal lesions without malignant transformation (p = 0.013). These data suggests that subjects with pre-neoplastic laryngeal lesion showing an increased susceptibility to carcinogens and with less proliferative disease could be at a higher risk for development of laryngeal carcinoma.
喉癌前病变发生恶性转化的相关因素在很大程度上仍不清楚。潜在的病因可能与对环境致癌物的遗传控制敏感性有关。在本研究中,我们采用匹配配对分析方法,调查了15例喉角化病患者在随访期间癌前病变发生恶性转化时博来霉素诱导的染色体脆性情况,并与15例在10年随访期间喉角化病无进展的历史对照者的染色体脆性情况进行了比较。染色体分析表明,喉癌前病变发生恶性进展的患者对致断裂剂的敏感性高于其原始喉角化病未进展的对照患者(p<0.01)。此外,为了确定可能的预后标志物,我们研究了两组非侵袭性和侵袭性喉病变活检样本中的增殖活性(MIB-1表达)和p53基因畸变情况。在15例癌前病变中有10例(66.7%)观察到p53免疫染色阳性,在15例同期喉癌中有11例(73.3%)观察到p53免疫染色阳性。转化病变和未转化病变在p53表达方面未观察到差异。在15例侵袭前活检样本中有3例(20%)观察到p53基因发生突变,在分析的5例喉癌中有4例(80%)观察到p53基因发生突变。我们的数据表明,p53改变是一部分喉癌发生过程中的早期事件,并且对于同一患者中p53突变的侵袭前疾病是否可能克隆发展为同期喉癌,尚无确凿数据。在转化病变(p=0.007)和未转化病变(p<0.1)中,均发现MIB-1表达随上皮增生和发育异常程度的增加而逐渐升高。令人惊讶的是,与无恶性转化的喉病变相比,发生肿瘤进展的侵袭前病变显示出较低的增殖活性(p=0.013)。这些数据表明,喉癌前病变患者若对致癌物敏感性增加且增殖性疾病较少,则发生喉癌的风险可能更高。